Ultrasonography thyroid volume estimation in hyperthyroid patients treated with individual radioiodine dose

Journal of Endocrinological Investigation

Volumn 30, Issue 4, 2007, Pages 318-322

  Massaro, F ^a   Vera, L ^a   Schiavo, M ^a   Lagasio, C ^a   Caputo, M ^a   Bagnasco, M ^a   Minuto, F ^a   Giusti, M ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Hyperthyroidism; RAI; Thyroid volume; Ultrasonography

Indexed keywords

LEVOTHYROXINE; PERTECHNETIC ACID TC 99M; RADIOACTIVE IODINE; THIAMAZOLE; THIONAMIDE DERIVATIVE; THYROTROPIN; THYROXINE;

ADULT; AGED; ARTICLE; CLINICAL EXAMINATION; CLINICAL PROTOCOL; CORRELATION ANALYSIS; DOSE CALCULATION; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; NODULAR GOITER; ORGAN SIZE; OUTCOME ASSESSMENT; PATIENT MONITORING; THYROID SCINTISCANNING; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TOXIC GOITER;

EID: 34347247625     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03346299     Document Type: Article

References (23)

1. Solomon B, Glinoer D, Lagasse R, Wartofsky L. Current trends in the management of Graves' disease. J Clin Endocrinol Metab 1990, 70: 1518-24.
2. Glinoer D, Hesch D, Lagasse R, Lauberg P. The management of hyperthyroidism due to Graves' disease in Europe in 1986. Results of an international survey. Acta Endocrinol (Copenh) 1987, 115 (Suppl): 1-23.
3. Singer PA, Cooper DS, Levy EG, et al. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. JAMA 1995, 273: 808-12.
4. AACE Thyroid Task Force. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Evaluation and Treatment of Hyperthyroidism and Hypothyroidism. Endocr Pract 2002, 8: 457-69.
5. Metso S, Jaatinen P, Huhtala H, Luukaala T, Oksala H, Salmi J. Long-term follow-up study of radioiodine treatment of hyperthyroidism. Clin Endocrinol (Oxf) 2004, 61: 641-8.
6. Smith RN, Wilson GM. Clinical trial of different doses of 131-I in treatment of thyrotoxicosis. BMJ 1967, 1: 129-32.
7. Jarlov AE, Hegedus L, Kristensen LO, Nygaard B, Hansen JM. Is calculation of the dose in radioiodine therapy of hyperthyroidism worth while? Clin Endocrinol (Oxf) 1995, 43: 325-9.
8. Peters H, Fischer C, Bogner U, Reiners C, Schleusener H. Radioiodine therapy of Graves' hyperthyroidism: standard vs. calculated 131 iodine activity. Results of a prospective, randomized multicentre study. Eur J Clin Invest 1995, 25: 186-93.
9. Leslie WD, Ward L, Salamon EA, Ludwig S, Lowe RC, Cowden EA. A randomized comparison of radioiodine doses in Graves' hyperthyroidism. J Clin Endocrinol Metab 2003, 88: 978-83.
10. Reinartz P, Sabri O, Zimny M, et al. Thyroid volume measurement in patients prior to radioiodine therapy: comparison between three-dimensional magnetic resonance imaging and ultrasonography. Thyroid 2002, 12: 713-7.
11. Traino AC, Di Martino F, Lazzeri M, Stabin MG. Influence of thyroid volume reduction on calculated dose in radioiodine therapy of Graves' hyperthyroidism. Phys Med Biol 2000; 45: 121-9.
12. Jonckeer MH, Glinoer D. A survey of modalities of the treatment of hyperthyroidism with radioiodine in Belgium. Acta Clin Belg 1988, 43: 267-72.
13. Wartofsky L. Radioiodine therapy for Graves' disease: case selection and restrictions recommended to patients in North America. Thyroid 1997, 7: 213-6.
14. Solomon DH. Treatment of Graves' hyperthyroidism. In: Ingbar SH, Braverman LE eds. Werner's The Thyroid, 5th ed. Philadelphia: JB Lippincott. 1986, 1001-5.
15. Nordyke RA, Gilbert FIJ. Optimal iodine-131 dose for eliminating hyperthyroidism in Graves' disease. J Nucl Med 1991, 32: 411-6.
16. Gittoes NJ, Franklyn JA. Hyperthyroidism. Current treatment guidelines. Drugs 1998, 55: 543-53.
17. Allahabadia A, Daykin J, Sheppard MC, Gough SC, Franklyn JA. Radioiodine treatment of hyperthyroidism - prognostic factors for outcome. J Clin Endocrinol Metab 2001, 86: 3611-7.
18. Kalinyak JE, McDougall IR. How should the dose of iodine-131 be determined in the treatment of Graves' hyperthyroidism? J Clin Endocrinol Metab 2003, 88: 975-7.
19. Beierwaltes WH. The treatment of hyperthyroidism with iodine-131. Semin Nucl Med 1978, 7: 95-103.
20. Franklyn JA, Daykin J, Drolc Z, Farmer M, Sheppard MC. Long-term follow-up of treatment of thyrotoxicosis by three different methods. Clin Endocrinol (Oxf) 1991, 34: 71-6.
21. Shapiro B. Optimization of radioiodine therapy of thyrotoxicosis: what have we learned after 50 years? J Nucl Med 1993, 34: 1638-41.
22. Catargi B, Leprat F, Guyot M, Valli N, Ducassou D, Tabain A. Optimized radioiodine therapy of Graves' disease: analysis of the delivered dose and other possible factors affecting outcome. Eur J Endocrinol 1999, 141: 117-21.
23. Holm LE, Lundell G, Israelsson A, Dhalqvist I. Incidence of hypothyroidism occurring long after iodine-131 therapy hyperthyroidism. J Nucl Med 1982, 23: 103-7.